{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:02:07Z","timestamp":1777982527309,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-026-10406-0","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:11:56Z","timestamp":1777255916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["All-site radiotherapy for metastatic ewing's sarcoma: a short-term analysis of feasibility, response, and safety"],"prefix":"10.1007","volume":"43","author":[{"given":"YuanYou","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"1","key":"10406_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/S41572-018-0003-X","volume":"4","author":"TGP Gr\u00fcnewald","year":"2018","unstructured":"Gr\u00fcnewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de \u00c1lava E, Kovar H et al (2018) Ewing sarcoma. Nat Rev Dis Primers 4(1):5. https:\/\/doi.org\/10.1038\/S41572-018-0003-X","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10406_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1200\/jco.2017.74.7402","volume":"36","author":"AS Pappo","year":"2018","unstructured":"Pappo AS, Dirksen U (2018) Rhabdomyosarcoma, Ewing sarcoma, and other round cell sarcomas. J Clin Oncol 36(2):168\u2013179. https:\/\/doi.org\/10.1200\/jco.2017.74.7402","journal-title":"J Clin Oncol"},{"key":"10406_CR3","first-page":"1412","volume-title":"Clinical radiation oncology","year":"2016","unstructured":"Gunderson LL, Tepper JE (eds) (2016) Clinical radiation oncology, Fourth Edition. Elsevier Health, Philadelphia, PA, pp 1412\u20131420","edition":"Fourth Edition"},{"issue":"2","key":"10406_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.21873\/anticanres.14028","volume":"40","author":"AM Karimi","year":"2020","unstructured":"Karimi AM, Campbell SR, Parsai S, Angelov L, Scott J, Qi P et al (2020) Aggressive local control with multisite stereotactic body radiation in metastatic Ewing sarcoma: a literature review and case report. Anticancer Res 40(2):951\u2013955. https:\/\/doi.org\/10.21873\/anticanres.14028","journal-title":"Anticancer Res"},{"key":"10406_CR5","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2,open-label trial. Lancet 393:2051\u20132058","journal-title":"Lancet"},{"key":"10406_CR6","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez DR, Tang C, Zhang JJ, Blumenschein GR Jr, Hernandez M, Lee JJ et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 37:1558\u20131565","journal-title":"J Clin Oncol"},{"issue":"2","key":"10406_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.prro.2024.10.004","volume":"15","author":"DL Casey","year":"2025","unstructured":"Casey DL, Murphy ES, Shen CJ, Milgrom SA, Larrier NA, Bradley JA et al (2025) Metastatic-site radiation therapy for Ewing sarcoma and rhabdomyosarcoma: consensus guidelines from the National Pediatric Cancer Foundation. Pract Radiat Oncol 15(2):180\u2013186. https:\/\/doi.org\/10.1016\/j.prro.2024.10.004","journal-title":"Pract Radiat Oncol"},{"key":"10406_CR8","unstructured":"NCCN clinical practice guidelines in oncology \u2013 Bone Cancer(Version 1.2025).https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bone.pdf."},{"issue":"1","key":"10406_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","volume":"112","author":"R Timmerman","year":"2022","unstructured":"Timmerman R (2022) A story of hypofractionation and the table on the wall. Int J Radiat Oncol Biol Phys 112(1):4\u201321. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.09.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10406_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"issue":"1","key":"10406_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijrobp.2016.04.001","volume":"96","author":"AC Talleur","year":"2016","unstructured":"Talleur AC, Navid F, Spunt SL, McCarville MB, Wu J, Mao SH et al (2016) Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control. Int J Radiat Oncol Biol Phys 96(1):119\u2013126. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.04.001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10406_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/pbc.25294","volume":"62","author":"DL Casey","year":"2015","unstructured":"Casey DL, Wexler LH, Meyers PA, Magnan H, Chou AJ, Wolden SL (2015) Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer 62(3):445\u2013449. https:\/\/doi.org\/10.1002\/pbc.25294","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10406_CR13","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1097\/MPH.0000000000001752","volume":"42","author":"AS Grewal","year":"2020","unstructured":"Grewal AS, Li YM, Grewal SK, Bagatell R, Balamuth N, Womer R et al (2020) Role of metastatic site irradiation in pediatric patients with metastatic Ewing sarcoma. J Pediatr Hematol Oncol 42(5):e305\u2013e309. https:\/\/doi.org\/10.1097\/MPH.0000000000001752","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10406_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/cncr.24740","volume":"116","author":"J Haeusler","year":"2010","unstructured":"Haeusler J, Ranft A, Boelling T, Gosheger G, Braun-Munzinger G, Vieth V et al (2010) The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer 116(2):443\u2013450. https:\/\/doi.org\/10.1002\/cncr.24740","journal-title":"Cancer"},{"key":"10406_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110270","volume":"195","author":"JK Bronk","year":"2024","unstructured":"Bronk JK, McAleer MF, McGovern SL, Lassen-Ramshad Y, Safwat A, Daw NC et al (2024) Comprehensive radiotherapy for pediatric Ewing sarcoma: outcomes of a prospective proton study. Radiother Oncol 195:110270. https:\/\/doi.org\/10.1016\/j.radonc.2024.110270","journal-title":"Radiother Oncol"},{"key":"10406_CR16","doi-asserted-by":"publisher","unstructured":"Ahmed SK, Robinson, Okuno SSH, Rose PS, Laack NNI. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease. Am J Clin Oncol. 2014;37(5):423\u20139. https:\/\/doi.org\/10.1097\/COC.0b013e31827de65e.","DOI":"10.1097\/COC.0b013e31827de65e"},{"issue":"11","key":"10406_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112789","volume":"13","author":"ME Abate","year":"2021","unstructured":"Abate ME, Cammelli S, Ronchi L, Diletto B, Gandola L, Paioli A et al (2021) Whole lung irradiation after high-dose Busulfan\/Melphalan in Ewing Sarcoma with lung metastases: an Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica joint study. Cancers (Basel) 13(11):2789. https:\/\/doi.org\/10.3390\/cancers13112789","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10406_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2217\/fon-2020-0066","volume":"16","author":"H Elghazawy","year":"2020","unstructured":"Elghazawy H, Nasr A, Zaky I, Zamzam M, Elgammal A, Farid N et al (2020) Whole lung irradiation for completely responding pulmonary metastases in pediatric Ewing sarcoma. Future Oncol 16(15):1043\u20131051. https:\/\/doi.org\/10.2217\/fon-2020-0066","journal-title":"Future Oncol"},{"issue":"3","key":"10406_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ijrobp.2018.06.032","volume":"102","author":"S Scobioala","year":"2018","unstructured":"Scobioala S, Ranft A, Wolters H, Jabar S, Paulussen M, Timmermann B et al (2018) Impact of whole lung irradiation on survival outcome in patients with lung relapsed Ewing Sarcoma. Int J Radiat Oncol Biol Phys 102(3):584\u2013592. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.032","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10406_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.828858","volume":"13","author":"J Bi","year":"2022","unstructured":"Bi J, Qian J, Yang D, Sun L, Lin S, Li Y, Xue X, Nie T, Verma V, Han G (2022) Dosimetric risk factors for acute radiation pneumonitis in patients with prior receipt of immune checkpoint inhibitors. Front Immunol 13(12):828858","journal-title":"Front Immunol"},{"issue":"190","key":"10406_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110040","volume":"1","author":"J Bi","year":"2024","unstructured":"Bi J, Meng R, Yang D, Li Y, Cai J, Zhang L, Qian J, Xue X, Hu S, Yuan Z, Verma V (2024) Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis. Radioth Oncol. 1(190):110040","journal-title":"Radioth Oncol."},{"issue":"4","key":"10406_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ijrobp.2022.10.001","volume":"115","author":"DA Cunningham","year":"2023","unstructured":"Cunningham DA, Breen WG, Johnson JE, Mullikin TC, Bradley TB, Sorenson KL et al (2023) Proton whole-lung irradiation: initial report of outcomes. Int J Radiat Oncol Biol Phys 115(4):866\u2013872. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.10.001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10406_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1013359","volume":"13","author":"EDG Fleuren","year":"2023","unstructured":"Fleuren EDG, Vlenterie M, van der Graaf WTA (2023) Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma. Front Oncol 13:1013359. https:\/\/doi.org\/10.3389\/fonc.2023.1013359. (eCollection 2023)","journal-title":"Front Oncol"},{"issue":"7","key":"10406_CR24","doi-asserted-by":"publisher","first-page":"e1256","DOI":"10.1002\/onco.13726","volume":"26","author":"J Xu","year":"2021","unstructured":"Xu J, Xie L, Sun X, Liu KS, Tang XD, Yan TQ et al (2021) Anlotinib, Vincristine, and Irinotecan for advanced Ewing Sarcoma after failure of standard multimodal therapy: a two-cohort, phase Ib\/II trial. Oncologist 26(7):e1256\u2013e1262. https:\/\/doi.org\/10.1002\/onco.13726","journal-title":"Oncologist"},{"issue":"21","key":"10406_CR25","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1002\/cam4.4286","volume":"10","author":"ZY Liu","year":"2021","unstructured":"Liu ZY, Gao ST, Zhu LY, Wang JQ, Zhang P, Li P et al (2021) Efficacy and safety of anlotinib in patients with unresectable or metastatic bone sarcoma: a retrospective multiple institution study. Cancer Med 10(21):7593\u20137600. https:\/\/doi.org\/10.1002\/cam4.4286","journal-title":"Cancer Med"},{"key":"10406_CR26","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.2147\/CMAR.S181087","volume":"10","author":"YT Wang","year":"2018","unstructured":"Wang YT, Min L, Zhou Y, Luo Y, Duan H, Tu CQ (2018) The efficacy and safety of apatinib in Ewing\u2019s sarcoma: a retrospective analysis in one institution. Cancer Manag Res 10:6835\u20136842. https:\/\/doi.org\/10.2147\/CMAR.S181087. (eCollection 2018)","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10406_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1667\/RADE-20-00017","volume":"194","author":"CM Callaghan","year":"2020","unstructured":"Callaghan CM, Seyedin SN, Mohiuddin IH, Hawkes KL, Petronek MS, Anderson CM et al (2020) The effect of concurrent stereotactic body radiation and Anti-PD-1 therapy for recurrent metastatic sarcoma. Radiat Res 194(2):124\u2013132. https:\/\/doi.org\/10.1667\/RADE-20-00017","journal-title":"Radiat Res"},{"issue":"6","key":"10406_CR28","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/cas.70042","volume":"116","author":"J Xie","year":"2025","unstructured":"Xie J, Mellado-Lagarde MM, Blankenship K, Ganguly D, Twarog NR, Bianski B et al (2025) The combination of PARP and topoisomerase 1 inhibitors improves radiation therapy for Ewing Sarcoma. Cancer Sci 116(6):1703\u20131714. https:\/\/doi.org\/10.1111\/cas.70042","journal-title":"Cancer Sci"},{"issue":"1","key":"10406_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70140","volume":"15","author":"PY Lam","year":"2025","unstructured":"Lam PY, Omer N, Wong JKM, Tu C, Alim L, Rossi GR et al (2025) Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR. Clin Transl Med 15(1):e70140. https:\/\/doi.org\/10.1002\/ctm2.70140","journal-title":"Clin Transl Med"},{"issue":"5","key":"10406_CR30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/0360-3016(94)90305-0","volume":"30","author":"EJ Hall","year":"1994","unstructured":"Hall EJ (1994) Molecular biology in radiation therapy: the potential impact of recombinant technology on clinical practice. Int J Radiat Oncol Biol Phys 30(5):1019\u20131028. https:\/\/doi.org\/10.1016\/0360-3016(94)90305-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10406_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00066-018-01422-5","volume":"195","author":"SGC Kroeze","year":"2019","unstructured":"Kroeze SGC, Fritz C, Basler L, Gkika E, Brunner TB, Grosu AL et al (2019) Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries. Strahlenther Onkol 195(3):199\u2013206. https:\/\/doi.org\/10.1007\/s00066-018-01422-5","journal-title":"Strahlenther Onkol"},{"key":"10406_CR32","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/OTT.S89755","volume":"9","author":"E Mart\u00ednez","year":"2016","unstructured":"Mart\u00ednez E, Mart\u00ednez M, Rico M, Hern\u00e1ndez B, Casas F, Vi\u00f1olas N et al (2016) Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial. Onco Targets Ther 9:1057\u20131066. https:\/\/doi.org\/10.2147\/OTT.S89755. (eCollection 2016)","journal-title":"Onco Targets Ther"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-026-10406-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:11:57Z","timestamp":1777255917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-026-10406-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["10406"],"URL":"https:\/\/doi.org\/10.1007\/s10585-026-10406-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8350070\/v1","asserted-by":"object"}]},"ISSN":["1573-7276"],"issn-type":[{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the World Medical Association Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Peking University Shougang Hospital (Approval No.: IRB-AF-37\u201403\u20142). Written informed consent was obtained from all individual participants (or their parents\/legal guardians in the case of minors [under the age of 16]) prior to treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all individual participants (or their parents\/legal guardians for those under 16) for the publication of their personal or clinical details and any identifying images included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests as defined by the journal, or other interests that might be perceived to influence the results and\/or discussion reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}